Herbs (Global Traditional) · European
Catnip (Nepeta cataria) (Nepeta cataria)
Moderate Evidencebotanical1 PubMed Study
Hermetica Superfood Encyclopedia
Catnip (Nepeta cataria) contains bioactive compounds like nepetalactone and quercitrin that demonstrate hepatoprotective and antioxidant properties. Research shows quercitrin at 50 mg/kg protected against liver injury in animal studies, while methanolic extracts exhibited 77.26% DPPH radical scavenging activity.
Catnip (Nepeta cataria) is a perennial herb in the mint family (Lamiaceae), native to Europe and Asia but now naturalized globally. The aerial parts (leaves, stems, flowers) are harvested and processed via methanol/hydroalcoholic extraction for polyphenolic compounds or steam distillation for essential oils (yielding 0.19-0.93%).
No human clinical trials, RCTs, or meta-analyses on Nepeta cataria were identified in the current research. All available evidence comes from phytochemical analyses, in vitro antioxidant assays, and limited animal studies examining hepatoprotective effects of isolated compounds.
No clinically studied human dosage ranges are available. Animal studies used isolated polyphenols at 50 mg/kg orally. Essential oil yields vary from 0.19-0.93% with no established dosing guidelines. Consult a healthcare provider before starting any new supplement.
Catnip (Nepeta cataria) is a low-calorie aromatic herb with nutritional data primarily derived from phytochemical analyses rather than comprehensive macronutrient studies. Bioactive compounds dominate its nutritional significance: Polyphenols are the most characterized fraction, with quercitrin (quercetin-3-rhamnoside) quantified at 8406.31 μg/g dry weight, making it the dominant flavonoid; chlorogenic acid measured at 1647.3 μg/g dry weight as a key hydroxycinnamic acid derivative. Nepetalactone iridoids (cis-trans and trans-cis isomers) constitute 70–99% of the essential oil fraction and are responsible for the characteristic feline behavioral response; these are largely volatile and lost during drying or cooking, limiting bioavailability in typical culinary use. Rosmarinic acid, luteolin, and apigenin glycosides have been identified as secondary polyphenolic constituents in methanolic extracts. The methanolic extract demonstrated 77.26% DPPH radical scavenging activity in vitro, attributable primarily to the high quercitrin content. Fiber content is moderate as expected for a leafy herb (estimated 2–4 g/100g fresh weight based on comparable Lamiaceae species), though specific values for N. cataria are not well-documented. Mineral content has not been specifically quantified in peer-reviewed literature; comparable herbs in the Lamiaceae family typically contribute calcium, magnesium, potassium, and iron in small amounts per typical serving. Protein content is low (~3–4 g/100g dry weight estimated by family comparison). Bioavailability note: Quercitrin requires intestinal deglycosylation to quercetin aglycone before absorption; bioavailability is moderate (~20–50% relative to quercetin standards). Nepetalactones are highly volatile and bioavailability via oral consumption is not well-characterized. Most compositional data derives from laboratory extractions rather than food preparation contexts, limiting direct nutritional translation.
Catnip's hepatoprotective effects are primarily attributed to quercitrin, a flavonoid glycoside that protects liver cells against oxidative damage induced by carbon tetrachloride (CCl4). The antioxidant activity stems from phenolic compounds in methanolic extracts that neutralize DPPH radicals through hydrogen donation. Nepetalactone, the primary volatile compound, may contribute to additional bioactive effects through interaction with cellular receptors.
Current evidence for catnip's health benefits comes primarily from preliminary animal studies and in vitro research. One rat study demonstrated that isolated quercitrin at 50 mg/kg provided significant protection against CCl4-induced liver injury. Laboratory tests showed methanolic catnip extracts achieved 77.26% DPPH radical scavenging activity, indicating strong antioxidant potential. Human clinical trials are lacking, making it difficult to establish definitive therapeutic benefits or optimal dosing for people.
Catnip is generally recognized as safe when used as a culinary herb or mild tea, with centuries of traditional use. However, concentrated extracts may cause drowsiness, headaches, or digestive upset in sensitive individuals. Pregnant and breastfeeding women should avoid medicinal amounts due to lack of safety data. No specific drug interactions are well-documented, but catnip may theoretically enhance the effects of sedative medications due to its mild calming properties.
